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Atrial (ANP) and C-type (CNP) natriuretic peptide generate physiological effects via selective ac-
tivation of two closely related membrane receptors with guanylyl cyclase (GC) activity, known as
GC-A and GC-B. As yet, however, the discrete roles for ANP/GC-A vs. CNP/GC-B signaling in many
mammalian tissues are still poorly understood. We here used receptor affinity labeling and GC
assays to characterize comparatively GC-A/GC-B expression and functional activity during rat brain
development. The study revealed that GC-B predominates in the developing and GC-A in the adult
brain, with regional differences each between cerebral cortex, cerebellum, and brain stem. Whereas
GC-A levels nearly continuously increase between embryonal d 18 and adult, GC-B expression in brain
is highest andwidely distributedaroundpostnatal d 1. The strikingperinatalGC-Bpeak coincideswith
elevatedexpressionofnestin,amarkerproteinforneural stem/progenitorcells. Immunohistochemical
investigations revealeda cell body-restricted subcellular localizationofGC-Bandperinatal abundance
of GC-B-expressing cells in regions high in nestin-expressing cells. However, and supported by exam-
ination of nestin-GFP transgenic mice, GC-B and nestin are not coexpressed in the same cells. Rather,
GC-B cells aredistinguishedbyexpressionofNeuN,anearlymarkerofdifferentiatingneurons. These
findings suggest that GC-B cells represent neuronal fate-specific progeny of nestin progen-
itors and raise the attention to specific and pronounced activities of CNP/GC-B signaling during
perinatal brain maturation. The absence of this activity may cause the neurological disorders
observed in GC-B-deficient mice. (Endocrinology 150: 5520–5529, 2009)
The members of the natriuretic peptide (NP) family,atrial (ANP), B-type (BNP) and C-type (CNP) NP
signal via binding to and stimulation of transmembrane
receptors with guanylyl cyclase (GC) activity, resulting
in intracellular accumulations of the second messenger,
cGMP. ANP and BNP are cardiac hormones that use
the same receptor, referred to as GC-A [also known
as NP receptor (NPR)-A], for signal transduction (1, 2).
In contrast, CNP operates in a paracrine/autocrine
manner and is the specific agonist for GC-B (NPR-B)
(1, 2).
The physiological impact of natriuretic peptide/GC/
cGMP signaling in mammals is broad, ranging from reg-
ulation of blood pressure and fluid volume homeostasis
(main target organs: vasculature, kidney, adrenal) to cru-
cial effects exerted in a variety of other organ systems (1,
2). GC-A and GC-B are closely related proteins (3), and
both are widely distributed among tissues (4, 5). Hith-
erto, only certain biological effects could be clearly as-
signed to either GC-A or GC-B signaling. These include
the inhibition of adrenal aldosterone secretion (byANP/
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GC-A) (6, 7) and the regulation of bone growth byCNP/
GC-B (8, 9).
The brain is one of the NP target tissues where the
specific roles for GC-A and GC-B are poorly understood.
Based on examinations at themRNA level and by receptor
autoradiography (reviewed in Ref. 10), NPs and their re-
ceptors seem present and widely distributed in the central
nervous system (CNS). Signaling by NPs has been linked
to neuronal functions such as neurotransmitter release,
synaptic transmission, axonal branching, neuroprotec-
tion, and neuroendocrine regulation (10, 11). Highlight-
ing an additional aspect of physiological significance,
there is accumulating evidence that natriuretic peptides
play roles during brain development (10, 12). Corre-
sponding data include the demonstration of discrete NP
and receptor gene expression patterns in the embryonic
brain (13). Functionally, there is evidence that NP-GC-
cGMPsignaling controls axonalbifurcationandpathfind-
ing during nervous system development (14) and pro-
motes the differentiation of olfactory neuronal precursor
cells (15). Assessments of postnatal time courses of ANP
and CNP gene expression (16) revealed transiently ele-
vated expression levels in different rat brain regions, fur-
ther supportingNP functions in developmental processes.
As yet, analogous investigations of GC-A and GC-B, re-
sponsible for mediating the cellular effects of ANP and
CNP, have not been reported. In addition, discrepancies
between gene expression analyses and data derived by re-
ceptor autoradiography suggested the existence of NP-
interacting proteins structurally different from the known
NPRs (12). Thus, experimental efforts to characterize un-
ambiguously these receptors in brain were desirable.
The present investigation aimed to resolve the expres-
sion profiles of GC-A and GC-B in the developing and
adult rat brain. To characterize the native proteins in a
conclusive manner, we used complementary approaches
involving receptor detection at the molecular level by af-
finity labeling and assessments of their agonist-dependent
enzyme activities. These studies revealed a directly op-
posed postnatal developmental regulation of the two
cGMP-generating NPRs. The resulting strong expression
ofGC-A in the adult brain suggests a predominant activity
of this receptor in terminally differentiated cell types of the
mature CNS. In contrast, an intriguing perinatal expres-
sion peak of GC-B, coinciding with transiently elevated
expression of the neuroepithelial stem/progenitor cell
marker protein nestin (17, 18), pointed at functions for
GC-B in the context of proliferation and/or maturation of
neural progenitor cells. Immunohistochemical investiga-
tions revealed mostly overlapping regional distribution
patterns of nestin and GC-B cells but no coexpression
of the two antigens in individual cells. Coexpression of
GC-B with neuronal nuclei (NeuN), a neuron-specific nu-
clear antigen that marks maturing and differentiated neu-
rons (19), indicates a dynamic role for CNP/GC-B signal-
ing in neurogenesis with highest impact during perinatal
development.
Materials and Methods
Materials
The synthetic peptides ANP (residues 1-28, rat) and CNP
(residues 32-53, rat) were purchased from Bachem (Weil am
Rhein, Germany), 125I-ANP (IM 186; 2 kCi/mmol) from Amer-
sham (Freiburg, Germany). 125I-[Tyr0]CNP32-53, 2.2 kCi/
mmol,was prepared at the PeptideRadioiodination ServiceCen-
ter (University, MS). 1-Methyl-3-isobutyl xanthine was from
Sigma (Taufkirchen, Germany) and protease inhibitors were
from Roche (Mannheim, Germany).
Animals and tissues
Wistar rats (CharlesRiver Laboratories, Sulzbach,Germany)
of different developmental stages were dissected after decapita-
tion, and the tissues were immediately frozen in liquid nitrogen
and stored at 80 C. Embryonic brains (n  4–6 each) were
pooledbeforehomogenization.Embryonic andpostnatal day (P)
1 brains, unless otherwise specified, were derived from both
males and females. All other rat tissues were frommale animals.
Nestin-green fluorescent protein (GFP) transgenic mice were de-
scribed previously (20). The animalswere used according to gov-
ernment principles regarding the care and use of animals with
permission (G8151/591-00.33) of the local regulatory authority.
Preparation of membrane and soluble protein
fractions
Protein fractions were prepared as described (21). In brief,
frozen tissueswere pulverized in amortar and then homogenized
using a Potter-Elvehjem homogenizer. After centrifugation at
3,000  g to remove cell debris and nuclei, proteins were sepa-
rated into soluble and particulate (membrane) fractions by cen-
trifugation at 100,000  g. Protein concentrations were deter-
minedbyusing akit fromBio-Rad (Munich,Germany)withBSA
(Sigma; fraction V) as standard.
Receptor affinity labeling
Protocols for photoaffinity labeling of natriuretic peptide re-
ceptors in crude membranes by 125I-ANP (4) or 125I-[Tyr0]CNP
(22) have been reported before. In brief, membranes were incu-
bated with radiolabeled ANP (0.5 nM) or CNP (2 nM), ligand/
receptor cross-links were induced by UV light irradiation, and
reaction products were analyzed by SDS-PAGE under reducing
conditions in 7.0% acrylamide separation gels followed by au-
toradiography at 70 C using XAR-5 film (Kodak, Rochester,
NY) and intensifying screens. Radiolabeled receptors, excised
from dried gels, were quantified in a BF 5300 -counter
(Berthold, Bad Wildbad, Germany).
Assay of particulate (membrane) GC activity
The protocol for determination of basal and NP-stimulated
GC activity in crudemembrane preparations has been published
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before (23). Assays were performed for 12 min in either the
absence or presence (1 M) of ANP or CNP, respectively, and
reactionswere startedbyadditionof10gofmembraneprotein.
Measurements of cGMP by a commercial ELISA (IHF, Ham-
burg, Germany) were described previously (4).
Immunoblotting
After separation by SDS-PAGE under reducing conditions,
proteins were transferred to nitrocellulose membranes as spec-
ified before (23). Blots were stained with Ponceau S (P7170;
Sigma), and the protein images were used to control protein
loading. After blocking (23), blots were exposed to antibodies
directed against GC-A (PGCA-101AP; Fabgennix, Frisco, TX),
GC-B (PGCB-201AP; Fabgennix), nestin (MAB353; Chemicon,
Temecula, CA), neuronal nitric oxide synthase (nNOS; 610308;
BD Biosciences, San Jose, CA), neurofilament-H (NF-H, NA
1209; Biotrend, Ko¨ln, Germany), glial fibrillary acidic protein
(GFAP; G3893; Sigma), or 2, 3-cyclic nucleotide 3-phospho-
diesterase (CNPase; MAB 326R; Chemicon). After incubation
with goat antirabbit or antimouse IgG (Pierce, Rockford, IL),
linked to peroxidase, signals were detected via enhanced chemi-
luminescence (23).
Immunofluorescence
Brains fromP1Wistar ratswere removedenblockand treated
overnight with 4% paraformaldehyde in PBS, followed by in-
cubation for 24h in 18%sucrose in PBS.Organswere embedded
in Tissue-Tek OCT compound (Sakura, Zoeterwoude, The
Netherlands), frozen in liquid nitrogen, and cut into 10-m sec-
tions. After blocking of unspecific protein binding sites by 2%
normal goat serum (Sigma) in PBS, the sections were incubated
overnight with anti-GC-B (FabGennix; 1:50), anti-GFAP (Sig-
ma; 1:1000), antinestin (Chemicon; 1:100), and/or anti-NeuN
(MAB 377; Chemicon; 1:100) followed by simultaneous expo-
sure to Cy3-conjugated goat antirabbit IgG (Jackson Immu-
noResearch, West Grove, PA; 1:500), Alexa Fluor 488 goat an-
timouse IgG (Molecular Probes, Eugene, OR; 1:1000), and 4,6-
diamidino-2-phenyl-inodole (DAPI; 1 g/ml) for 1 h at room
temperature. Sections, in which primary antibodies were omit-
ted, served as controls. Images were obtained by conventional
fluorescence microscopy (Axioskop 2; Zeiss, Oberkochen, Ger-
many) or confocal laser scanning microscopy (TCS SP5; Leica,
Wetzlar, Germany).
Nestin-GFP transgenic mice of P1 were fixed with 4% para-
formaldehyde/PBS for 7 h and then placed into 30%sucrose/PBS
for 2 d. Brains were removed and embedded in Tissue-Tek (see
above). For detection ofGFP fluorescence (24) and simultaneous
immunofluorescence analyses (see above), 10-m sections were
used.
Experimental reproducibility and data analysis
All results shown were representative of at least three inde-
pendent experiments performed. For densitometric quantifica-
tion, ImageJ (open source; NIH, Bethesda, MD) was used. Data
were graphed and analyzed using Prism 3.02 (GraphPad Soft-
ware Inc., San Diego, CA). The significance of effects was as-
sessed using Student’s t test.
Results
Assessment of NPR expression by photoaffinity
labeling
Rat pineal gland membranes, characterized previously
by exceptionally high expression levels ofGC-B (22),were
used in initial experiments to judge and optimize experi-
mental conditions for photoaffinity labeling of this recep-
tor. Based on a more than 10-fold reduced affinity of io-
dinated forms of Tyr0-CNP for GC-B (25), the sensitivity
of GC-B detection by the photoaffinity labeling approach
is markedly lower than that of analogous GC-A detection
assays with iodinated ANP. The specific labeling of GC-B
by 125I-Tyr0-CNPafterUV light irradiation (supplemental
Fig. S1, published as supplemental data on The Endo-
crine Society’s Journals Online web site at http://endo.
endojournals.org), and the results of experimental efforts
to increase the yield of GC-B labeling (supplemental Fig.
S2) are shown. Further studies served to prove the recep-
tor-specificity (GC-A vs. GC-B) of the photoaffinity la-
beling approach (supplemental Fig. S3).
GC-A and GC-B are differentially regulated during
development in brain
To examine comparativelyGC-B andGC-A expression
during brain development, membrane preparations from
rat brains of different embryonic day (E; 18 and 20), post-
natal (P1-28), and adult (Ad., 3 months) stages were in-
cubatedwith either 125I-Tyr0-CNPor 125I-ANPbeforeUV
light-induced ligand/receptor cross-linking, and reaction
products were analyzed by SDS-PAGE and autoradiogra-
phy. These studies revealed a massive increase in GC-A
expression during ontogeny (Fig. 1A). As calculated by
-countingof the excised radiolabeled receptorbands, this
increase was 20-fold between E18 and adult. Comparing
P1 and adult, the increase was 6-fold.
A completely different developmental regulation was
observed in the case ofGC-B. This receptorwas detectable
only at early developmental stages, with a pronounced
expression peak at P1 (Fig. 1B). Considering the above-
mentioned reduced sensitivity of GC-B detection by the
photoaffinity labeling approach, these findings clearly re-
vealed strikingly high perinatal levels ofGC-B in brain but
could not be used to predict an absence of GC-B expres-
sion at later developmental stages.
Immunoblot analyses were consistent with the pho-
toaffinity labeling data and confirmed the decrease in
GC-B (and the increase in GC-A) levels between P1 and
adult (Fig. 1C). As specificity controls, we coexamined
receptor expression in membranes from rat adrenal, rep-
resenting a major GC-A expression site (4) and pineal
gland, an outstanding GC-B expression site (22). These
studies in addition corroborated apreviously reported size
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shift (i.e. a decrease in kilodaltons) of GC-A during post-
natal brain development (4).
We next investigated comparatively, by GC assays, the
agonist-dependent enzymatic activities of GC-A and
GC-B in perinatal and adult brain. Consistent with the
protein expression data, theGC-B ligand, CNP, generated
higher cGMP accumulations than ANP (acting on GC-A)
at P1 membranes, whereas ANP was the more effective
peptide in the case of adult membranes (Fig. 2A). With
maximal 3.3-fold (CNP at P1) and 2.8-fold (ANP at adult
brain membranes) increases in GC activity, the peptide-
elicited effects were limited. In our experience, a restricted
sensitivity to agonist stimulation is typical for membrane
preparations, from either native tissues or cell lines endo-
genously expressing NPRs (26). Several experimental ef-
forts to enhance GC stimulation by the receptor ligands
remained unsuccessful. Neither the addition of phospha-
tase inhibitors (to prevent dephosphorylation/desensitiza-
tion of GC-A and GC-B) during tissue homogenization
(supplemental Fig. S4) nor the presence of protease inhib-
itors during peptide exposure (bacitracin, up to 2 mg/ml;
data not shown) couldmarkedly elevate ligand-dependent
GC activities. Also, cGMP production did not differ sig-
nificantly between freshly prepared (never frozen) mem-
branes and membranes after storage at 80 C (supple-
mental Fig. S5). Thus, disruption of the cellular plasma
membrane topology during homogenization might essen-
tially contribute to reduced agonist sensitivity.
As disclosed by assays with brain membranes from dif-
ferent developmental stages, GC-B activity predominates
before birth and postnatally at least until P7 (Fig. 2B).
GC-A-mediated cGMP production begins to exceed that
FIG. 1. Developmental regulation of GC-A and GC-B. A, Rat brain
membranes (50 g protein) derived from different embryonic (E18 and
E20) or postnatal (P1-28; Ad., 3 months old) stages were incubated
with 125I-ANP, ligand/receptor cross-links were induced by UV
irradiation, and reaction products were analyzed via SDS-PAGE and
autoradiography. The resulting radiolabeled ANP receptor (GC-A)
bands are shown at the top. For quanitification, receptor bands were
excised from the dried gels, and the amounts of radioactivity were
measured by -counting. The graph shows the mean  SE of four
experiments. B, The same experiments as in A were performed with
125I-Tyr0-CNP instead of 125I-ANP. Radiolabeled GC-B bands from a
representative experiment (top) and the quantitative evaluation of four
experiments are shown. C, Immunoblots comparing levels of GC-A
(upper panel) or GC-B (lower panel) in equal amounts (60 g) of
membrane protein from rat brain (P1 vs. Ad.), adrenal, and pineal
gland (adult each).
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FIG. 2. ANP- and CNP-dependent cGMP production by brain
membranes from different developmental stages. A, Production of
cGMP in the absence (basal) or presence (1 M) of ANP or CNP by
brain membranes (10 g protein) from either neonatal (P1) or adult
animals. Amounts of cGMP were determined by ELISA. The data
represent the mean  SE of four independent experiments each. *, P 
0.005 vs. ANP (P1) or CNP (Ad.). B, Basal and ANP- and CNP-induced
cGMP production by brain membranes (10 g protein) from different
developmental stages (indicated) was measured as in A. Values
obtained in the presence of the peptides were divided through the
yields of cGMP measured in the absence of agonists each and
expressed as fold stimulation vs. basal. Data shown are mean  SE of
three separate experiments. C, Production of cGMP in the absence
(basal) or presence (1 M) of ANP or CNP by P1 brain membranes (10
g protein) from either male or female rats. Amounts of cGMP were
determined by ELISA. *, P  0.001 vs. ANP, n  4 each. There are no
significant differences between male and female cGMP levels.
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ofGC-B between P7 and P14 (Fig. 2B). Remarkably, basal
GC activities aremuch higher at P1 than in the adult brain
(see Fig. 2A).Adetailed analysis, indicating towhat extent
this activity varies during development, is shown (supple-
mental Fig. S6).
Basal as well as ANP- and CNP-elicited cGMP accu-
mulations did not differ between brain membranes de-
rived frommales or females at P1 (Fig. 2C), indicating that
the high perinatal GC-B expression is a gender-indepen-
dent phenomenon.
High GC-B expression in brain at P1 is widely
distributed and most prominent in the cerebral
cortex
We next questioned whether the abundant GC-B ex-
pression around birth, observed in whole brain tissue, is
based on a broad receptor distribution or due to high con-
centrations in only a subset of brain areas. GC assays with
membranes from isolated cerebral cortex, cerebellum, and
brain stem (Fig. 3A) demonstrated that CNP is highly ef-
fective and more potent at generating cGMP than ANP
in all three areas at P1. Thus, GC-B is widely distributed
in brain after birth and represents the predominant NPR
in each one of the regions examined. This investigation
also revealed that cerebral cortex is distinguished by both
the highest levels of GC-B and the lowest levels of GC-A
activity at P1. Analogous assays with membrane prepa-
rations fromadult animals showed (Fig. 3B) thatANPwas
more effective thanCNP to generate cGMP.Highest levels
of GC-A activity were found in cerebellum and brain stem
membranes. By comparing the alterations between P1 and
adult, GC-B-mediated cGMP formation decreases most
significantly in the cerebral cortex, and GC-A-mediated
cGMP formation increasesmost vigorously in cerebellum.
The perinatal expression peak of GC-B coincides
with nestin (a marker for neural stem/progenitor
cells) expression
Taking into account the abundant and widespread ex-
pression of GC-B in whole brain tissue at P1, indicating
quantitatively significant amounts of GC-B expressing
cells, we examined by immunoblot analyses the expression
levelsofproteins representingmarkermolecules fordifferent
cell types in the brain. These experiments demonstrated an
onlyverypoor expressionatP1of cell type-specificmarkers
for terminally differentiated neurons (NF-H), oligoden-
drocytes (CNPase) and astrocytes (GFAP) in either soluble
or particulate brain protein fractions (Fig. 4A). As ex-
pected, these proteins are abundant in the adult brain.
Analogous examinations of nNOS, which is expressed in
developing and differentiated neurons (27), revealed a
substantial expression at P1 and a less pronounced in-
crease in adult tissue (Fig. 4A).
These findings focused the attention on cells acting as
progenitors for the differentiated cell types of the mature
brain.Corresponding analyses of nestin, amarker for neu-
roepithelial stem cells (17, 18), revealed a perinatal (from
E20 to P14) developmental expression profile (Fig. 4B), in
part reminiscent of that ofGC-B (Fig. 1B). Althoughnestin
levelsweremoreabundantatE18 thanatP1, consistentwith
observations in nestin-GFP transgenic mice that overall nes-
tin expression is highest in thedevelopingbrainbetweenE14
and 15 (20), we observed a decrease fromE18 to E20 before
the formation of a subsequent expression peak around birth
(Fig. 4C). The correlation of the latter with the perinatal
GC-B expression peak disclosed a temporally confined
(around birth) developmental stage during which transient
increases inneuralprogenitorcellactivity (deducedfromnes-
tin expression) and GC-B expression coincide.
The appearance of additional nestin-immunoreactive
bands (Fig. 4B) likely represents nestin degradation prod-
ucts, which are typically seen in such analyses (28). Re-
garding the apparent molecular mass of nestin, usually
estimated from the positions of comigrated size marker
proteins, some previous studies (24, 29) assessed values
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FIG. 3. GC assays with membranes from different brain regions. A,
Assessment of basal and ANP- and CNP-dependent cGMP production
by membranes from the P1 brain regions indicated. CNP elicits
significantly (**, P  0.001; *, P  0.05) more cGMP than ANP in all
regions (n  3 each). B, Basal and ANP- and CNP-dependent cGMP
production by membranes from different Ad. brain regions. ANP is
more effective than CNP (**, P  0.001; *, P  0.05) in raising cGMP
levels (n  5 each).
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(440 kDa) obviously incompatible with the expected
molecular weight of 200,000 by cDNA analysis (17). We
addressed this discrepancy by analyzing identical samples
in different gel systems and found (data not shown) an
anomalous (i.e. retarded) gel migration behavior of nestin
at low (6%) acrylamide concentrations.
Nestin- and GC-B-expressing cells are in close
proximity
The high perinatal (P1) expression levels of GC-B sug-
gested a considerable frequency of GC-B-expressing cells
at that stage. This was confirmed by immunohistochem-
ical investigations. Examinations of P1 rat brain sections
revealed large amounts andabroaddistributionofGC-B
cells in the cerebral cortex as well as a predominantly cell
body-localized receptor immunoreactivity (Fig. 5, A and
B). Consistentwith analyses ofGC-B enzyme activity (Fig.
3), GC-B cells were less abundant in brain stem (Fig. 5C)
and cerebellum (not shown). As expected, there was a
broad andmassive expression of nestin in P1 brain (Fig. 5,
A and C). Compared with nestin, GFAP was poorly de-
tectable and showed a much more restricted regional dis-
tribution, for themost part at brain surface areas (Fig. 5B).
GC-B and nestin cells were in close proximity in all
brain regions (Fig. 5, A andC). Locally the ratio ofGC-B
to nestin cells in such regions varied appreciably, ranging
from areas with a great excess of nestin cells to those in
which GC-B cells were accumulated (Fig. 5, A and C).
Enhanced resolution by confocal microscopy confirmed
the mostly perikarya localization of GC-B and revealed a
FIG. 4. Immunoblot analyses of marker proteins for neural cell types.
A, Soluble and particulate (60 g protein each) fractions of brain
homogenates from either P1 or Ad. rats were examined by
immunoblotting for NF-H, CNPase, GFAP, and nNOS. Protein sizes (in
kilodaltons), calculated from comigrated reference proteins, are
shown. B, Immunoblot for nestin of soluble rat brain proteins (20 g)
from different embryonic (E18 and E20) and postnatal (P1-28)
developmental stages including Ad. (3 months). C, Densitometric
quantification of nestin levels. Data are from three independent
immunoblot analyses. For each blot, densitometry scores were
normalized to the value obtained for nestin expression at P1. Bars,
Mean scores  SE in relation to those for P1 (set as 1). Nestin levels at
P1 were significantly (*, P  0.05) higher than those at E20 and P7.
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FIG. 5. GC-B- and nestin-expressing cells in P1 brain. A, C, and D,
Codistribution of nestin and GC-B IR. Nestin-positive fibers and GC-B-
positive perikarya are present in areas of the neonatal rat cerebral
cortex (A) and brain stem (C and D) in close proximity (A: fluorescence
microscopy, nuclei are stained with DAPI; C and D: confocal
microscopy). B, GC-B and GFAP IR. GFAP, poorly detectable at P1, is
visible in certain distance to GC-B cells near the surface of the frontal
cortex. DAPI marks nuclei. E–G, Visualization of nestin-GFP and GC-B
IR in different regions of the P1 cerebral cortex (E and F) and close to
the lateral ventricle (l.v.; G) from nestin-GFP transgenic mice. Sites of
coexpression (would appear in yellow) are undetectable (E: shorter
exposure times to focus on GFP nuclei; F: longer exposure time to
visualize both cell bodies and processes). Bars, 20 m.
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punctual appearance of receptor immunoreactivity (IR)
(Fig. 5, C and D).
The overlapping distribution of nestin and GC-B IR
raised the possibility of cells that coexpress both antigens.
Due to the different subcellular localization of nestin (cell
processes) andGC-B (perikarya), corresponding clear-cut
assessments by double-labeling studies were difficult. To
circumvent this handicap, we used nestin-GFP transgenic
mice based on findings that GFP in these animals is de-
tectable also in the nuclei of nestin-expressing cells (20).
Examinations of P1 brains demonstrated abundant oc-
currence of GC-B cells also in mice and provided con-
vincing evidence for the absence of cells that coexpress
nestin and GC-B (Fig. 5, E–G). Remarkably, the periven-
tricular surfaces, known sites of particularly high concen-
trations of nestin (20, 30), are devoid of GC-B IR. Accu-
mulations of GC-B cells were detectable at different
distances to the ventricular zones (Fig. 5G).
GC-B cells at P1 are characterized by NeuN
expression
The above distribution and coexpression analyses sug-
gested that GC-B cells may represent progeny of nestin
progenitor cells. Because nestin expression decreases when
cells proceed toward neuronal differentiation (20), we ex-
amined the expression of NeuN, a neuron-specific and
mainly nuclear protein thought to represent an earlymarker
of neuronal differentiation (19). These investigations re-
vealed that GC-B cells are characterized by NeuN expres-
sion (Fig. 6). Whereas all GC-B cells were NeuN positive,
the degree of GC-B IR associated with NeuN cells varied
strongly between individual cells, and major amounts of
NeuN cells without detectable GC-B expression were evi-
dent (Fig. 6A). Interestingly, the NeuN/GC-B coexpressing
cells seemed to be distinguished by a higher-than-average
intensity of NeuN IR and the appearance of perinuclear in
addition to nuclear staining (Fig. 6, B–E). There is also evi-
dence thatGC-B andNeuN IR can extend a certain distance
into cell processes (see inset in panel A and panel D).
Discussion
NPR expression in the developing and adult brain
Expression of GC-A in brain tissues was well verifiable
by affinity-labeling experiments. Previous comparative
examinations of GC-A levels in different central and pe-
ripheral rat tissues (4) have shown that the early postnatal
brain represents an exceedinglypoorGC-Aexpression site
in vivo. The possibility to visualize the even lower con-
centrations of this receptor in prenatal brain tissues dem-
onstrates thehigh sensitivity and favorableusabilityof this
approach.Representing a further advantage of the affinity
labeling approach, 125I-ANP binds and becomes co-
valently linked to both GC-A (120–130 kDa) and a third
NPR, NPR-C, of 60 kDa (23). Expression of NPR-C is
seen by such experiments in diverse tissues, ranging from
testis and fat (23) to lung,kidney, andchoroidplexus (data
not shown). However, and as demonstrated before (4),
NeuN + GC-B
GC-B
DAPI
GC-BNeuN
Merge
CB
A
ED
FIG. 6. Coexpression of GC-B and NeuN in P1 brain. A, Nerve cells,
stained by NeuN, in a representative region of the cerebral cortex in P1
rat brain (confocal microscopy). NeuN is predominantly visible in cell
nuclei. Neurons coexpressing NeuN and GC-B are easily detectable.
The inset shows one of these cells at higher magnification. Note the
GC-B-positive neurite. B–E, Magnification of an area in which NeuN/
GC-B-coexpressing cells reside (fluorescence microscopy). B, NeuN IR is
detectable with different staining intensity between individual cells
and is not exclusively restricted to the nuclei (see D and E; note
especially the cell marked by an arrow). C, Visualization of
perikarya-localized GC-B IR. D, Yellow color marks sites of NeuN/
GC-B coexpression in the cytoplasm. E, Visualization of GC-B IR and
cell nuclei by DAPI. Bars, 20 m.
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NPR-C expression remained undetectable in both early
postnatal and adult brainmembranes. These findings sug-
gest that NPR-C does not play a major role during brain
maturation. In addition, our study failed to provide evi-
dence for a discussed (12) potential existence of atypical
ANP receptors in brain.
Detection of GC-B by affinity-labeling with 125I-Tyr0-
CNP, despite the positive effect induced by inclusion of
0.1% sodium dodecyl sulfate (supplemental Fig. S2) re-
mained restricted to tissues with exceptionally high recep-
tor levels. In addition to the perinatal brain, adult pineal
glands, and pituitaries (22) represent such tissues.
The exceptionally high expression of GC-B at P1 was
confirmed by immunoblot analyses and GC assays, and
these approaches allowed to assess the expression of the
receptor also in the adult brain. We recognized some no-
table region-specific peculiarities. The cerebral cortexwas
found to be distinguished by the highest expression of
GC-B at P1 and poor expression levels of both receptors in
the adult. Consistently, the cerebellum and brain stem
turned out to be themajor sites ofGC-A expressionwithin
the adult brain. These data suggest that the cerebral cortex
is a key target tissue for CNP during perinatal develop-
ment and indicates particularly pronounced signaling ac-
tivities ofANPwithin the adult cerebellumandbrain stem.
Because ANP- and CNP-stimulated cGMP production
by P1 brain membranes was indiscriminative between
males and females, there was no evidence for gender-
related differences in perinatal NP receptor expression.
It should be noted that we did not find a quantitative
correlation between receptor levels and their agonist-de-
pendent cGMP production. Whether the perikarya local-
ization of GC-B, proposed alterations in GC-A glycosyl-
ation during brain development (4) and/or developmental
changes in the amount of receptor phosphorylation (and
hence activity) are involved, remains to be addressed.
Perinatal abundance of GC-B in brain and
coincidence with nestin expression
The high levels of GC-B (but not GC-A) in the embry-
onic and early postnatal brain suggested specific functions
for CNP signaling in brain development. In support of
this, CNP gene expression was detectable in mouse brain
already at the onset of neurogenesis (E10.5) and increased
further 4 d later, whereas ANP (and BNP) transcripts re-
mained undetectable in embryonic brain (13). The high
levels ofGC-Bprotein (Fig. 1B) andCNP-dependentGC-B
activity (Fig. 2B) at the late embryonic stages (E18 and
E20), each exceeding those in the adult brain, suggests that
GC-B is present andactive even at earlier embryonic stages
including the beginning of neurogenesis. However, the
pronounced peak ofGC-B expression around P1 indicates
a maximum activity at the perinatal period.
The strikingly similar developmental expression profiles
of GC-B and nestin between E20 and P14 suggested either a
synchronized functional interrelationship between nestin-
expressing neural stem/progenitor cells and GC-B-express-
ing cells and/or the existence of cell populations with coex-
pression of these proteins. In any case, these findings
endorsed a role for CNP in processes of neurogenesis.
Characterization of GC-B cells
Immunohistochemical investigations revealed high
amounts of GC-B IR in the perinatal brain and elucidated
a major perikarya localization of the receptor. Consistent
with the results of GC assays (Fig. 3A) and supporting
signal specificity, the overall occurrence of GC-B IR was
most prominent in the cerebral cortex. Further validation
derived from immunohistochemical investigations on rat
aorta sections, inwhichGC-B IRwas found tobe localized
to the known sites (endothelial and vascular smooth
muscle cells) of GC-B expression, and from Western
blot analyses (Fig. 1C)with the sameantibody.Analogous
examinations performed with anti-GC-A did not show
GC-B-comparable IR, and the only detectable staining at
P1was localized to blood vessels. On adult brain sections,
GC-A IR was prominent on processes (e.g. axons) of ma-
ture neurons (not shown).
GC-B cells were codistributed with sites of nestin ex-
pression, supporting the idea of a functional interrelation
including the possibility of coexpression at the cellular
level. To be able to address the latter question in a con-
clusive manner by double-labeling experiments, we made
use of nestin-GFP transgenic mice, in which nestin-
expressing cells are labeled by GFP also in the nuclear
compartment (20). These studies negated the existence of
cells that coexpress the two proteins and raised the atten-
tion to progeny of nestin cells. The overlapping distri-
bution patterns of nestin and GC-B IR, and the observa-
tion of areas in which either nestin- or GC-B-expressing
cells predominate,were indicativeof suchan interrelation.
The pronounced perinatal expression peak of GC-B sug-
gests a transient emergence of a relatively abundant cell
population with pronounced GC-B expression. This pro-
cess might be even more dynamic if one considers the het-
erogeneous distribution (and varying relative accumula-
tion) of these cells and their presumed nestin-expressing
progenitors. Thus, at the single-cell level, there should be
amarkedly rapid turnover ofGC-Bexpression.During the
onset of GC-B expression, large amounts of maturing (in-
tracellular) GC-B precursors should be detectable under
such conditions. On the other hand, the subsequent de-
crease in GC-B expression might involve receptor inter-
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nalization/endocytosis events, which also favors the oc-
currence of intracellular immunoreactivity. In apparent
support of these theoretical considerations, enhanced res-
olution by confocal laser-scanning microscopy (Fig. 5D)
revealed a punctual appearance of intracellular GC-B.
Consistentwith other investigations (20, 30), we found
that nestin expression at P1 is highly accumulated in cell
layers surrounding the ventricles. However, in both nes-
tin-GFP mice and rats, we saw a broad and significant
expression of nestin in other cortical areas, brain stem and
cerebellum at this developmental stage. These findings are
in full agreement with previously reported data (30). As
evident from the present study (images in Fig. 5), the pro-
posed interrelationship between nestin- and GC-B-
expressing cells seems to concern these areas rather than
the periventricular zone. Moreover, it can be proposed
that the transient increase in nestin expression between
E20 and P1 takes place in these areas.
The identification of GC-B coexpression with NeuN
revealed that GC-B expression at P1marks neuronal cells.
NeuN is expressed in postmitotic neurons and appears
first when cells initiate cellular and morphological differ-
entiation (19). Thus, GC-B expressionmay be a feature of
early neuronal progeny of nestin cells.Most remarkably,
we recognized that GC-B expression in NeuN cells was
correlated with peculiarities in the intensity and subcellu-
lar distribution of NeuN IR. It has been suggested that the
intensity of NeuN labeling can differ between individual
cells in relation to their acute physiological state (19, 31).
In addition, NeuN is not exclusively expressed in nuclei
but also detectable in the cytoplasm (19, 32). Functional
roles forNeuNprotein in the nucleus and evenmore in the
cytoplasm are not yet understood. Our present findings, in-
dicating enhanced nuclear staining intensity and the appear-
ance of perinuclear IR in those NeuN cells that coexpress
GC-B,arethereforeremarkable.Thesepropertiesmaydefine
an early neuronal cell population in which CNP-GC-B-
cGMP signaling and yet enigmatic roles ofNeuN contribute
to a distinct activity status. Distinct periods (both pre- and
postnatal) of neuron generation are established (33), and
recent quantitative analyses of neurons and glia in the devel-
opingneocortexofmice revealed that thenumberofneurons
increased up to 100% between birth and P16 (34).
Possible signaling activities for CNP
Evidence for cellular functionsofCNPduringprocesses
ofneurogenesis came fromstudieswitholfactoryneuronal
precursors (15). CNP was found to block neurotrophin-
induced proliferation of these cells and promote their sur-
vival and maturation. The CNP effects were mimicked by
8-bromo-cGMP but not ANP or BNP, verifying the spe-
cific involvement and activity of GC-B. Indicating poten-
tial molecular mechanisms involved, further studies
showed that CNP lowers the neurotrophin-mediated ex-
pressionof cyclinD1and simultaneously induces different
inhibitory cell cycle proteins, apparently correlating with
the attainment of different maturational cell fates (35).
Providing evidence for an additional role of CNP during
neural development, which is related to patterning events,
the peptide was found to increase in mouse embryonic
hindbrain cultures the expression of the sonic hedgehog
target gene gli-1 (13). Considering the compartmentalized
manner of cGMP signaling (1), all these reported cellular
effects of CNP are compatible with the major perikarya
localization of GC-B elucidated in the present study.
Although histological abnormalities were not detected in
the brain of GC-B knockout mice, these animals showed
symptoms(self-clasping,priapism)ofneuronaldisorders (9).
Close inspection of the dorsal root entry zone in mice with
inactivatedGC-Brevealed thatGC-B-cGMPsignaling is crit-
ical for proper sensory axon bifurcation during nervous sys-
temdevelopment (14).Reducedamounts of dorsal root gan-
glion neurons were found in CNP knockout mice (36).
Conclusion
Perinatal andearlypostnatal neurogenesis, affectingmany
CNSregions including the cerebral cortex, contributes sig-
nificantly to brain maturation (33, 34, 37, 38). The tran-
sition process from neural stem cells to fully differentiated
neurons and glia cells involves a cascade of distinct steps
and different subtypes of precursor cells that differ inmor-
phology, marker protein expression and mitotic activity
(20, 39).Our present findings provide evidence thatGC-B
expression specifically marks early neuronal progeny of
nestin-expressing progenitor cells and suggest that CNP/
GC-B/cGMP signaling controls perinatal stages of brain
maturation. Neurological disorders in GC-B-deficient
mice (9) suggest physiological importance. Our findings
also uncover an example for discrete roles of GC-A and
GC-B signaling in the same target organ.
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